Sebastian A. Wohlfeil^1,2,3,*, Jochen S. Utikal^1,2,3

Oncology Research, Vol.34, No.6, 2026, DOI:10.32604/or.2026.078650 - 21 May 2026

Abstract Over the past decade, the therapeutic paradigm of cutaneous melanoma has been transformed strongly, driven by advances in immuno-oncology and precision medicine. Building on the success of immune checkpoint blockade and targeted therapy, new treatment strategies now aim to improve efficacy, overcome resistance, and prolong the durability of responses. Clinical trials on neoadjuvant therapy supporting its clinical use are presented. Furthermore, the latest progress in combinatorial immune checkpoint inhibition such as dual anti-LAG-3 or anti-TIGIT with anti-PD-1 blockade, next-generation bispecific antibody development, mRNA-based vaccines in clinical practice, and intralesional therapies are summarized. Additionally, it outlines More >

Maria Franza, Aurora Melfi, Filippo Acconcia, Alessandra di Masi^*

Oncology Research, Vol.34, No.6, 2026, DOI:10.32604/or.2026.076509 - 21 May 2026

Abstract Checkpoint kinase 1 (CHK1), a key regulator of cell cycle checkpoints, plays a central role in the DNA damage response network, serving as a critical mediator that links DNA damage detection to DNA repair mechanisms. In recent years, several other cellular functions of CHK1 have gradually been discovered. As well as monitoring genomic integrity, CHK1 coordinates the timing of DNA replication with the availability of metabolic resources. This prevents unscheduled DNA synthesis from exceeding the cell’s metabolic capacity and causing DNA damage. CHK1 activity also contributes to tumour immune surveillance and the modulation of immune… More >

Denisse A. Gutierrez^*, Elisa Robles-Escajeda, Jose A. Lopez-Saenz, Robert A. Kirken, Edgar A. Borrego, Ana P. Betancourt, Soumya Nair, Sourav Roy, Armando Varela-Ramirez, Renato J. Aguilera^*

Oncology Research, Vol.34, No.4, 2026, DOI:10.32604/or.2026.074945 - 23 March 2026

Abstract Objectives: Drug resistance is the major determinant of chemotherapy failure, leading to relapse and tumor progression, demonstrating the urgent need for novel antineoplastic drugs. This study aimed to evaluate the anticancer potential of two novel pyrazole derivatives, P3C.1 and P3C.2, and to elucidate their mechanism of action in cancer cells. Methods: The cytotoxicity of the compounds was evaluated across 27 different cancer cell lines via a nuclear staining assay. Subsequent flow cytometric and biochemical analyses were performed to assess reactive oxygen species (ROS) generation, apoptosis induction, mitochondrial integrity, and cell cycle progression. Additional studies included… More >

Yuanxin Miao^1,2, Fengyun Hao^3,*, Sae Hwi Ki^1,4,*

Oncology Research, Vol.34, No.3, 2026, DOI:10.32604/or.2025.071034 - 24 February 2026

Abstract Objectives: The eukaryotic initiation factor 4F (eIF4F) translation initiation complex inhibitors (eIF4Fi) were recently found to hyperactivate extracellular signal-regulated kinases 1/2 (ERK1/2) signals, which contribute to acquired resistance to BRAF (B-Raf proto-oncogene, serine/threonine kinase) inhibitors in melanoma. This present study aims to elucidate how to overcome the resistance of the eIF4Fi in BRAF^V600E mutant melanoma cells and explore the underlying mechanisms. Methods: Melanoma A375 (vemurafenib [VEM]-sensitive) and A375R (VEM-resistant) cells were exposed to eIF4Fi RocA at varying doses and durations in vitro. We investigated the impact of RocA on the activity of ERK1/2, AKT serine/threonine kinase 1… More >

Md Salah Uddin^*

Journal of Polymer Materials, Vol.42, No.4, pp. 1051-1073, 2025, DOI:10.32604/jpm.2025.070688 - 26 December 2025

Abstract Carbon fiber-reinforced composites (CFRCs) have a wide range of applications in the aerospace, automotive, and energy sectors. A higher specific strength-to-weight ratio is desired in high-performance applications. The failure mechanism of CFRCs involves multiscale phenomena, such as failure that can occur at the matrix, fibers, interface, layers, lamina, and laminates. When an impactor hits the CFRCs, the design involves analyzing each of these stages to prevent failure and optimize the properties of CFRCs under various loading conditions. A numerical model was employed to predict the fracture toughness of CFRCs with varying weight fractions and orientations.… More >

Cheng Song^1,*, Iftikhar Hussein Shah², Ghulam Abbas Ashraf³, Muhammad Arif⁴, Muhammad Aamir Manzoor^1,5,*

Phyton-International Journal of Experimental Botany, Vol.94, No.11, pp. 3427-3451, 2025, DOI:10.32604/phyton.2025.070778 - 01 December 2025

Abstract Heavy metal pollution has become a pervasive environmental issue affecting numerous regions worldwide. Recently, there has been significant attention given to the application of nano-enabled technologies with the purpose of enhancing plant development and alleviating heavy metal stress. This study aimed to illustrate the potential of zinc oxide nanoparticles (ZnO-NPs) to enhance the morphological traits of D. huoshenense exposed to cadmium (Cd) stress. The chemical structure and elemental composition of the ZnO-NPs were characterised by a series of analytical methods, including X-ray diffraction, UV-Vis spectrometry, XPS, and TEM. Plant samples used were collected at 0, 5,… More > Graphic Abstract

Fangyuan Li^1,2,#, Xiaoyuan Hu^1,#, Xiaoge Gao³, Ling Liu³, Tao Li¹, Dan He¹, Jiaxing Cheng¹, Xiaobiao Ma¹, Li Li^1,*, Chunlei Ge^1,*, Hong Yao^1,*

Oncology Research, Vol.33, No.12, pp. 4029-4048, 2025, DOI:10.32604/or.2025.067628 - 27 November 2025

Abstract Background: Liver cancer stem cells (LCSCs) are recognized as pivotal drivers of hepatocellular carcinoma (HCC) progression; however, the molecular mechanisms maintaining their stem-like phenotype remain largely unresolved. This work investigates the role of prefoldin subunit 6-like protein (PFDN6L) in shaping LCSC traits and promoting or restraining HCC progression. Methods: PFDN6L, a cytoskeleton-associated chaperone, was studied using multiple in vitro assays—cell growth evaluation, cell cycle profiling, and spheroid culture—alongside analyses of stemness-associated markers (SOX2, CD133, CD44). Tumorigenic capacity was assessed in xenograft mouse models, and signaling pathway interrogation was performed to define underlying mechanisms. Results: In patient samples, More >

Luyao Sun^#, Ronghao Zhang^#, Kexin Su, Mengjie Wang, Kai Wang, Xiaoyu Wang^*

BIOCELL, Vol.49, No.11, pp. 2217-2237, 2025, DOI:10.32604/biocell.2025.068450 - 24 November 2025

Abstract Objectives: An allergy is an exaggerated immune response, and mast cells play central roles in allergic pathologies. Allyl isothiocyanate can suppress inflammatory responses; however, whether allyl isothiocyanate has a suppressive effect on allergic pathologies remains unclear. Methods: 2,4-dinitrofluorobenzen or ovalbumin was used to establish a mouse model of allergic contact dermatitis or food allergy, respectively. The mRNA level of cytokines was determined using real-time polymerase chain reaction. To examine the effects of allyl isothiocyanate on mast cells, degranulation and intracellular calcium measurement, RNA sequencing, real-time polymerase chain reaction, and Western blotting were performed. Results: Allyl isothiocyanate… More >

Chuansheng Yang¹, Xiaoling Zhou^2,3, Ling Luo³, Zirun Luo⁴, Kaiming Fan^5,*, Chenglai Xia^2,3,*

Oncology Research, Vol.33, No.10, pp. 3065-3076, 2025, DOI:10.32604/or.2025.066058 - 26 September 2025

Abstract Objectives: Novel drug delivery systems have been designed to enhance local drug concentrations while reducing side effects conducive to improved breast cancer treatment outcomes. This study aimed to identify the anti-cancer function of zeolite imidazole ester-based material loaded with camptothecin nanoparticles. Methods: We utilized a zeolitic imidazolate backbone material to fabricate 9-hydroxycamptothecin nanoparticles and investigated their impact on breast cancer cell proliferation. Scanning electron microscopy and Fourier-transform infrared spectroscopy revealed changes in the carrier skeleton of the loaded 9-hydroxyl camptothecin, characterized by a reduction in surface smoothness, accompanied by slight collapses and folds on the… More >

Tatiana M. Astakhova, Nikita S. Karpov, Nataliya O. Dashenkova, Elena V. Alpeeva, Mikhail V. Nesterchuk, Sergey B. Akopov, Arsen S. Mikaelyan, Anfisa S. Ryabchenko, Pavel A. Erokhov, Natalia P. Sharova^*

Oncology Research, Vol.33, No.9, pp. 2573-2595, 2025, DOI:10.32604/or.2025.066611 - 28 August 2025

Abstract Objectives: Proteasomes, multi-subunit proteases, are key actors of cellular protein catabolism and a number of regulatory processes. The detection of subtle proteasome functioning in tumors may contribute to our understanding of the mechanisms of cancer development. The current study aimed to identify the role of low molecular mass protein 2 (LMP2), a proteasome immune subunit, in the development of mouse colon 26 (C26) adenocarcinoma. Methods: The functions of the LMP2 subunit in tumor development in Balb/c mice were studied using its irreversible inhibitor KZR-504. LMP2 activity was detected by the hydrolysis of the fluorogenic substrate… More >